Outcome Modifying Genes in Sickle Cell Disease | NHLBI Trans-Omics for Precision Medicine Skip to main content

Outcome Modifying Genes in Sickle Cell Disease

Short Name
OMG_SCD
Institution(s)
Duke University
Type of Omics
WGS
Approx. Sample Size 675
Disease/Phenotype
sickle cell disease
Starting Phase
Phase 2
dbGaP ID
phs001608
TOPMed Accession #
Please see this TOPMed Project's Parent Studies.
Omics Center(s) Phase 2
Baylor College of Medicine Human Genome Sequencing Center
Specify the TOPMed Phase for the Omics Center(s) selected above
7.1
Omics Center Contact
Donna Muzny
Phases Involved
2
Populations
Adult Patients with SCD from NC and GA
PI

Allison Ashley-Koch
Co-PI
Marilyn Telen
Contact

Allison Ashley-Koch
Steering Committee Representatives
Allison Ashley-Koch
Marilyn Telen
P&P primary
Allison Ashley-Koch
Project
OMG_SCD
Released
No